Learn more

• Understanding lymphoma
• Lymphoma treatment
• Bone marrow/stem cell transplant
• Our team

What makes us different

Expertise: Our providers work in groups that focus on specific types of lymphoma. Our detailed understanding of over 80 types of lymphoma ensures that you receive treatments tailored to your needs.

Innovations: Our CEO, Dr. Brian Druker, is an internationally renowned pioneer in cancer medicine and an expert in blood cancers. Dr. Druker helped develop Gleevec, a lifesaving daily pill that turned a deadly type of leukemia into a manageable illness. His work launched precision cancer medicine, showing that cancer can be defeated at the molecular level.

National recognition: We’ve earned the National Cancer Institute’s top designation for leadership in research.

Complete care

Second opinions: Our providers are sought after for second opinions to make sure you have the best treatment plan for your type of lymphoma.

Care in your community: When possible, our patients can receive certain treatments close to home, delivered by a community cancer doctor with guidance from your OHSU team.

Outstanding hospital care: Our Center for Hematologic Malignancies (blood cancers) inpatient unit includes advanced practitioners, nurses with specialty training, and chemotherapy pharmacists. It continually ranks in the top 5% nationally for patient satisfaction.

Molecular profiling: We use advanced technology to examine the DNA in patient samples. This helps us understand lymphoma at the molecular level so we can target treatments based on your genetic information.

Support services: Our nurse coordinators and cancer social workers can help you with issues around transportation, financial concerns and making appointments. We also provide services for patients who live far from OHSU.

Advanced bone marrow/stem cell transplants: We offer one of the nation's leading bone marrow/stem cell transplant centers. We are the only Oregon center to provide transplants that use donor cells, giving you more options. After a transplant, we work with you and your primary care doctor to manage side effects or other concerns through the Bone Marrow Transplant Survivorship Program.

Clinical trials and research

The Knight Cancer Institute is a world center for cancer research. Our goal is to turn discoveries in the lab into improvements in patient care as quickly as possible.

• Clinical trials: We are leading hundreds of clinical trials to test new ways to prevent, detect, diagnose and treat cancer.
• Early detection: Our Cancer Early Detection Advanced Research Center has some of the best minds in cancer seeking ways to detect cancer earlier, when it’s most curable.
• Cancer registries: Cancer registries are databases of patient information that help scientists understand how diseases progress and work toward cures. Learn about our registries, including one for bone marrow transplant patients, and find out how you can contribute to research.
• Robotics in the laboratory: Our blood disorder research uses robotics to help us test multiple medications and doses at one time. This means we can develop new treatments faster.